Peter P De Cruz

Credit Name
Peter P De Cruz
Full Name
De Cruz, Peter P
Variants
De Cruz, Peter
Department
ORCID

Journal Title
- 6 Inflammatory bowel diseases
- 4 Alimentary Pharmacology & Therapeutics
- 4 Journal of Crohn's & colitis
- 1 Alimentary pharmacology & therapeutics
- 1 Clinical Gastroenterology and Hepatology
- 1 Clinics in liver disease
- 1 Gut
- 1 Gut microbes
- 1 Inflammatory Bowel Diseases
- 1 Internal Medicine Journal
- 1 Journal of Gastroenterology and Hepatology
- 1 The Lancet. Gastroenterology & Hepatology
- 1 World Journal of Gastroenterology
Date issued
Type
Results 1-20 of 24 (Search time: 0.014 seconds).
Publication Year | Title | Author(s) | |
---|---|---|---|
1 | 1-Nov-2020 | Luminal microbiota related to Crohn's disease recurrence after surgery. | Hamilton, Amy L; Kamm, Michael A; De Cruz, Peter P ; Wright, Emily K; Feng, Hai; Wagner, Josef; Sung, Joseph J Y; Kirkwood, Carl D; Inouye, Michael; Teo, Shu-Mei |
2 | Sep-2020 | Immune therapies in ulcerative colitis: are we beyond anti-TNF yet? | Raine, Tim; Verstockt, Bram; De Cruz, Peter P |
3 | 16-Aug-2020 | Tofacitinib is Safe and Effective When Used in Combination With Infliximab for the Management of Refractory Ulcerative Colitis. | Gilmore, Robert ; Hilley, Patrick; Srinivasan, Ashish ; Choy, Matthew C ; Grace, Josephine A ; De Cruz, Peter P |
4 | 14-Aug-2020 | Vedolizumab for ulcerative colitis: Real world outcomes from a multicenter observational cohort of Australia and Oxford. | Pulusu, Samba Siva Reddy; Srinivasan, Ashish ; Krishnaprasad, Krupa; Cheng, Daniel; Begun, Jakob; Keung, Charlotte; Van Langenberg, Daniel; Thin, Lena; Mogilevski, Tamara; De Cruz, Peter P ; Radford-Smith, Graham; Flanagan, Emma; Bell, Sally; Kashkooli, Soleiman; Sparrow, Miles; Ghaly, Simon; Bampton, Peter; Sawyer, Elise; Connor, Susan; Rizvi, Quart-Ul-Ain; Andrews, Jane M; Mahy, Gillian; Chivers, Paola; Travis, Simon; Lawrance, Ian Craig |
5 | Aug-2020 | Letter: choosing between ustekinumab and vedolizumab in anti-TNF refractory Crohn's disease-the devil is in the detail. | Srinivasan, Ashish ; De Cruz, Peter P ; van Langenberg, Daniel R |
6 | Aug-2020 | Letter: ustekinumab dose intensification for loss of response-should we re-induce before shortening the dose interval? | Srinivasan, Ashish ; De Cruz, Peter P ; van Langenberg, Daniel R |
7 | 17-Jul-2020 | Anti-TNF-associated immunogenicity: use a retroactive drug but a proactive approach. | Srinivasan, Ashish ; De Cruz, Peter P ; van Langenberg, Daniel R |
8 | Jun-2020 | Letter: how can we reduce mortality in elderly patients with acute severe ulcerative colitis? | Li Wai Suen, Christopher F D; Choy, Matthew C ; De Cruz, Peter P |
9 | Jun-2020 | A virtual clinic increases anti-TNF dose intensification success via a treat-to-target approach compared with standard outpatient care in Crohn's disease. | Srinivasan, Ashish ; van Langenberg, Daniel R; Little, Robert D; Sparrow, Miles P; De Cruz, Peter P ; Ward, Mark G |
10 | 11-Apr-2020 | Letter to the Editor: Antibiotic Cocktail for Pediatric Acute Severe Colitis and the Microbiome: The PRASCO Randomized Controlled Trial. | Gilmore, Robert ; Choy, Matthew C ; Li Wai Suen, Christopher F D; De Cruz, Peter P |
11 | 11-Apr-2020 | Letter Re: Safety of Combination Biologic and Antirejection Therapy Post-liver Transplantation in Patients With Inflammatory Bowel Disease | Peverelle, Matthew R ; Mills, Chris; Testro, Adam G ; Gow, Paul J ; De Cruz, Peter P |
12 | 31-Mar-2020 | Ustekinumab is a safe and effective biologic agent for Crohn's disease in a Liver Transplant patient. | Peverelle, Matthew R ; Asadi, Khashayar; De Cruz, Peter P |
13 | Mar-2020 | Letter: infliximab induction regimens in steroid-refractory acute severe colitis-a propensity score analysis. | Li Wai Suen, Christopher F D; Choy, Matthew C ; De Cruz, Peter P |
14 | 20-Feb-2020 | Letter Re: Safety of Combination Biologic and Antirejection Therapy Post-liver Transplantation in Patients With Inflammatory Bowel Disease. | Peverelle, Matthew R ; Mills, Christopher D; Testro, Adam G ; Gow, Paul J ; De Cruz, Peter P |
15 | 16-Jan-2020 | Activity of Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis Predicts Poorer Clinical Outcomes. | Peverelle, Matthew R ; Paleri, Sarang; Hughes, Jed ; De Cruz, Peter P ; Gow, Paul J |
16 | 2020 | Using Ustekinumab to Treat Crohn's Disease-Related Orofacial Granulomatosis: Two Birds, One Stone. | Gilmore, Robert ; Li Wai Suen, Christopher F D; Elliott, Tim; De Cruz, Peter P ; Srinivasan, Ashish |
17 | 23-Aug-2019 | A Framework to support Quality of Care for patients with Chronic Intestinal Failure requiring Home Parenteral Nutrition. | Osland, Emma J; McGrath, Kathleen H; Ali, Azmat; Carey, Sharon; Daniells, Suzie; Angstmann, Katerina; Bines, Julie; Asrani, Varsha; Watson, Caitlin; Jones, Lynn; De Cruz, Peter P |
18 | Aug-2019 | Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Patients with Hematological and Solid Tumor Malignancies. | Sasadeusz, Joe; Grigg, Andrew P ; Hughes, Peter D; Lim, Seng Lee; Lucas, Michaela; McColl, Geoff; McLachlan, Sue Anne; Peters, Marion G; Shackel, Nicholas; Slavin, Monica; Sundararajan, Vijaya; Thompson, Alexander; Doyle, Joseph; Rickard, James; De Cruz, Peter P ; Gish, Robert G; Visvanathan, Kumar |
19 | 2019 | Quality of Care in Patients With Inflammatory Bowel Disease. | Jackson, Belinda D ; De Cruz, Peter P |
20 | 2019 | Systematic Review and Meta-analysis: Optimal Salvage Therapy in Acute Severe Ulcerative Colitis. | Choy, Matthew C ; Seah, Dean ; Faleck, David M; Shah, Shailja C; Chao, Che-Yung; An, Yoon-Kyo; Radford-Smith, Graham; Bessissow, Talat; Dubinsky, Marla C; Ford, Alexander C; Churilov, Leonid ; Yeomans, Neville D ; De Cruz, Peter P |